Table 1. Clinicopathologic Correlation of HSP60 Status in 223 Gastric Cancer.

Characteristics	No. of patients	Level of HSP60 (%)		P-value
		Negative	Positive
Gender
Male	144	56 (38.9%)	88 (61.1%)
Female	79	37 (46.8%)	42 (53.2%)	0.250
Age (years)
≤60	140	63 (45.0%)	77 (55.0%)
>60	83	30 (36.1%)	53 (63.9%)	0.195
Size (cm)
≤5.0	146	67 (45.9%)	79 (54.1%)
>5.0	77	26 (33.8%)	51 (63.2%)	0.081
Tumor site
Upper	88	32 (36.4%)	56 (63.6%)
Middle/Lower	135	61 (45.2%)	74 (54.8%)	0.192
Differentiation
Well/Moderate	100	42 (42.0%)	58 (58.0%)
Poor	123	51 (41.5%)	72 (58.5%)	0.936
Depth of invasion
T1/T2	88	44 (50.0%)	44 (50.0%)
T3/T4	135	49 (36.3%)	86 (63.7%)	0.043
Lymph node metastasis
Negative	65	35 (53.8%)	30 (46.2%)
Positive	158	58 (36.7%)	100 (63.3%)	0.018
Stages
I/II	112	54 (48.2%)	58 (51.8%)
III	111	39 (35.1%)	72 (64.9%)	0.048